Platinum Therapies

Injection of an radiopharmaceutical imaging agent

ANSTO's technology commercialisation successes include Platinum Therapies.

About Platinum Therapies - technology and development

Platinum based chemotherapeutic agents are used in the treatment of cancers. ANSTO patent technology involves the rapid and reliable synthetic method for platinum-based radiopharmaceuticals applicable to first, second and third generation platinum agents that includes 195mPt Cisplatin and 195mPt Carboplatin.

 
Commercial status: Clinical studies commencing in 2010

Inventor: Suzanne Smith

ANSTO Business Development contact: Joy Woods (+61 2 9717 9009)